- DXCM has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $138.1 million
- DXCM has traded 124,438 shares today
- DXCM is trading at a new lifetime high
EXCLUSIVE OFFER: Get the inside scoop on opportunities in DXCM with the Ticky from Trade-Ideas. See the FREE profile for DXCM NOW at Trade-Ideas More details on DXCM: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently there are nine analysts that rate DexCom a buy, one analyst rates it a sell, and three rate it a hold. The average volume for DexCom has been 667,400 shares per day over the past 30 days. DexCom has a market cap of $6.17 billion and is part of the health care sector and health services industry. The stock has a beta of 0.79 and a short float of 4.5% with 2.18 days to cover. Shares are up 44.6% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.